Get the Stockscreener App
9.50
0.00%
0.00
After Hours:
9.50
Corbus Pharmaceuticals Holdings Inc stock is traded at $9.50, with a volume of 75,107.
It is up +0.00% in the last 24 hours and up +6.03% over the past month.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
See More
Previous Close:
$9.50
Open:
$9.49
24h Volume:
75,107
Relative Volume:
0.55
Market Cap:
$116.42M
Revenue:
$1.54M
Net Income/Loss:
$-38.70M
P/E Ratio:
-2.0343
EPS:
-4.67
Net Cash Flow:
$-36.86M
1W Performance:
-3.65%
1M Performance:
+6.03%
6M Performance:
+37.48%
1Y Performance:
-81.58%
1-Day Range:
$9.30
$9.62
1-Week Range:
$9.30
$10.07
52-Week Range:
$4.64
$56.93
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
Name
Corbus Pharmaceuticals Holdings Inc
Sector
Industry
Phone
617-963-0103
Address
500 RIVER RIDGE DRIVE, NORWOOD, MA
Compare CRBP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRBP
Corbus Pharmaceuticals Holdings Inc
|
9.50 | 118.39M | 1.54M | -38.70M | -36.86M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-30-25 | Resumed | B. Riley Securities | Buy |
| Feb-28-25 | Initiated | William Blair | Outperform |
| Dec-02-24 | Initiated | Piper Sandler | Overweight |
| Jul-30-24 | Initiated | Wedbush | Outperform |
| Jul-22-24 | Resumed | H.C. Wainwright | Buy |
| Jun-26-24 | Initiated | B. Riley Securities | Buy |
| Jun-03-24 | Reiterated | Oppenheimer | Outperform |
| May-13-24 | Initiated | RBC Capital Mkts | Outperform |
| Mar-06-24 | Upgrade | Jefferies | Hold → Buy |
| Sep-08-20 | Downgrade | BTIG Research | Buy → Neutral |
| Sep-08-20 | Downgrade | Jefferies | Buy → Hold |
| Sep-08-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-08-20 | Downgrade | ROTH Capital | Buy → Neutral |
| Jul-07-20 | Initiated | ROTH Capital | Buy |
| Jun-17-20 | Initiated | BTIG Research | Buy |
| Mar-26-20 | Initiated | Nomura | Buy |
| Apr-05-19 | Initiated | Jefferies | Buy |
| Mar-20-19 | Initiated | Oppenheimer | Outperform |
| Jan-11-19 | Reiterated | Cantor Fitzgerald | Overweight |
| Dec-26-18 | Initiated | H.C. Wainwright | Buy |
| Dec-07-18 | Initiated | RBC Capital Mkts | Outperform |
| Oct-24-18 | Initiated | B. Riley FBR | Buy |
| Jan-19-18 | Initiated | Raymond James | Outperform |
| Dec-14-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Nov-08-17 | Reiterated | Noble Financial | Buy |
| Sep-29-17 | Resumed | Noble Financial | Buy |
| Mar-30-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Nov-15-16 | Reiterated | JMP Securities | Mkt Outperform |
| Nov-11-16 | Reiterated | Noble Financial | Buy |
View All
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Latest News
Can Corbus Pharmaceuticals Holdings Inc. recover in the next quarterPortfolio Risk Report & Reliable Price Action Trade Plans - Newser
What high frequency data says about Corbus Pharmaceuticals Holdings Inc.Trade Volume Report & Free Weekly Chart Analysis and Trade Guides - Newser
Corbus Pharmaceuticals Holdings Inc. stock volume spike explainedJuly 2025 Weekly Recap & Real-Time Chart Pattern Alerts - Newser
Does Corbus Pharmaceuticals Holdings Inc. show high probability of reboundWeekly Profit Analysis & Safe Entry Zone Identification - Newser
Chart based analysis of Corbus Pharmaceuticals Holdings Inc. trendsTrade Risk Summary & Technical Pattern Alert System - Newser
Signal strength of Corbus Pharmaceuticals Holdings Inc. stock in tech scannersBreakout Watch & Weekly Chart Analysis and Guides - Newser
Candlestick signals on Corbus Pharmaceuticals Holdings Inc. stock todayInsider Buying & Technical Confirmation Trade Alerts - Newser
Using portfolio simulators with Corbus Pharmaceuticals Holdings Inc. included2025 Pullback Review & Free Verified High Yield Trade Plans - Newser
Can momentum traders help lift Corbus Pharmaceuticals Holdings Inc.Weekly Stock Recap & Daily Profit Maximizing Tips - Newser
Does Corbus Pharmaceuticals Holdings Inc. fit your quant trading modelTrade Entry Summary & Technical Pattern Alert System - Newser
Can technical indicators confirm Corbus Pharmaceuticals Holdings Inc.’s reversalPortfolio Update Summary & Free Weekly Watchlist of Top Performers - Newser
Corbus Pharmaceuticals Holdings Inc.’s volatility index tracking explained2025 Market WrapUp & Safe Entry Zone Tips - Newser
Published on: 2025-09-12 05:41:05 - Newser
Published on: 2025-09-12 05:12:06 - Newser
Full technical analysis of Corbus Pharmaceuticals Holdings Inc. stock2025 Performance Recap & Step-by-Step Swing Trade Plans - Newser
Comerica Bank Increases Stake in Corbus Pharmaceuticals Holdings, Inc. $CRBP - MarketBeat
What MACD and RSI say about Corbus Pharmaceuticals Holdings Inc.2025 Historical Comparison & Smart Investment Allocation Tips - Newser
How to track smart money flows in Corbus Pharmaceuticals Holdings Inc.Long Setup & Stepwise Entry and Exit Trade Signals - Newser
Nuveen LLC Makes New Investment in Corbus Pharmaceuticals Holdings, Inc. $CRBP - MarketBeat
Exome Asset Management LLC Makes New Investment in Corbus Pharmaceuticals Holdings, Inc. $CRBP - MarketBeat
What candlestick patterns are forming on Corbus Pharmaceuticals Holdings Inc.Analyst Downgrade & Weekly High Momentum Picks - Newser
Using economic indicators to assess Corbus Pharmaceuticals Holdings Inc. potentialIndex Update & Free Community Supported Trade Ideas - Newser
Is Corbus Pharmaceuticals Holdings Inc. still worth holding after the dip2025 Trade Ideas & Technical Confirmation Trade Alerts - Newser
Published on: 2025-09-11 00:31:18 - Newser
What’s the recovery path for long term holders of Corbus Pharmaceuticals Holdings Inc.2025 Historical Comparison & Stepwise Swing Trade Plans - Newser
Will Corbus Pharmaceuticals Holdings Inc. see short term momentumGDP Growth & AI Forecast Swing Trade Picks - Newser
Published on: 2025-09-10 01:39:01 - Newser
Regression analysis insights on Corbus Pharmaceuticals Holdings Inc. performanceEarnings Summary Report & High Accuracy Trade Signal Alerts - Newser
Reversal indicators forming on Corbus Pharmaceuticals Holdings Inc. stock - Newser
Corbus Pharmaceuticals Holdings Inc. stock trend forecastPortfolio Performance Report & Accurate Technical Buy Alerts - Newser
Is this a good reentry point in Corbus Pharmaceuticals Holdings Inc.Insider Buying & Long Hold Capital Preservation Plans - Newser
Heatmap analysis for Corbus Pharmaceuticals Holdings Inc. and competitorsRecession Risk & Real-Time Market Trend Scan - Newser
Published on: 2025-09-09 04:13:55 - Newser
full technical analysis of corbus pharmaceuticals holdings inc. stockJuly 2025 Short Interest & Technical Entry and Exit Tips - Newser
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):